On January 27, 2025, an exclusive article by The Wall Street Journal announced that Manas AI, an artificial intelligence drug discovery start-up founded by Siddhartha Mukherjee, a Columbia professor and author of The Emperor of All Maladies, has launched with $24.6 million in initial funding. Manas AI will first focus on breast cancer, prostate cancer, and lymphoma before broadening its scope to include other illnesses. Tech investor and LinkedIn co-founder Reid Hoffman led the funding round with VC firm General Catalyst. Greylock also participated.

Wilson Sonsini Goodrich & Rosati represented Manas AI in the transaction. The Wilson Sonsini team was led by Yokum Taku, Jonathan Zhu, Avi Emanuel, and Jake Morales.

For more information, please see the full WSJ article or Manas AI's website.